EMA Authorised: Ivabradine Zentiva (ivabradine hydrochloride) — Zentiva, k.s.

View source ↗

Summary

The EMA authorised Ivabradine Zentiva (ivabradine hydrochloride) for use in angina pectoris and heart failure; Marketing authorization holder is Zentiva, k.s.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Angina Pectoris
• Heart Failure

Drugs mentioned

• Ivabradine Zentiva (ivabradine hydrochloride)

Snippet

Status: Authorised. Therapeutic area: Angina Pectoris;Heart Failure. MAH: Zentiva, k.s.. Decision date: 15/07/2025